PTC Therapeutics announce the launch of Emflaza for the treatment of Duchenne muscular dystrophy (DMD) within the coming weeks, with an expected net price of $35,000.
emflaza
-
-
April 24, 2017
The latest events surrounding the pricing of a Duchenne muscular dystrophy (DMD) treatment